
Erica S Y Lin
Examiner (ID: 4581, Phone: (571)270-7911 , Office: P/2853 )
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853, 2861 |
| Total Applications | 1103 |
| Issued Applications | 882 |
| Pending Applications | 99 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14406793
[patent_doc_number] => 20190169240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => DNA-BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/216617
[patent_app_country] => US
[patent_app_date] => 2018-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 376
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16216617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/216617 | DNA-BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF | Dec 10, 2018 | Abandoned |
Array
(
[id] => 18172846
[patent_doc_number] => 11572547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Fusion proteins for the detection of apoptosis
[patent_app_type] => utility
[patent_app_number] => 16/770551
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 6314
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770551 | Fusion proteins for the detection of apoptosis | Dec 5, 2018 | Issued |
Array
(
[id] => 18134922
[patent_doc_number] => 11560578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Neopinone isomerase and methods of using
[patent_app_type] => utility
[patent_app_number] => 16/770207
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 38
[patent_no_of_words] => 23605
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770207 | Neopinone isomerase and methods of using | Nov 28, 2018 | Issued |
Array
(
[id] => 14043923
[patent_doc_number] => 20190078068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same
[patent_app_type] => utility
[patent_app_number] => 16/196411
[patent_app_country] => US
[patent_app_date] => 2018-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16196411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/196411 | Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same | Nov 19, 2018 | Abandoned |
Array
(
[id] => 14519493
[patent_doc_number] => 10336994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Subtilisin variants having a mutation in the S2 or S2# pocket
[patent_app_type] => utility
[patent_app_number] => 16/193963
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 12992
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16193963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/193963 | Subtilisin variants having a mutation in the S2 or S2# pocket | Nov 15, 2018 | Issued |
Array
(
[id] => 18369351
[patent_doc_number] => 11649509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Anastasis biosensor caspase tracker
[patent_app_type] => utility
[patent_app_number] => 16/763849
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 8524
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763849 | Anastasis biosensor caspase tracker | Nov 15, 2018 | Issued |
Array
(
[id] => 16298022
[patent_doc_number] => 20200283745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => NUCLEAR-TARGETED DNA REPAIR ENZYMES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/762852
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762852
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762852 | NUCLEAR-TARGETED DNA REPAIR ENZYMES AND METHODS OF USE | Nov 13, 2018 | Abandoned |
Array
(
[id] => 14230541
[patent_doc_number] => 20190127443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 16/180456
[patent_app_country] => US
[patent_app_date] => 2018-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16180456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/180456 | Multivalent heteromultimer scaffold design and constructs | Nov 4, 2018 | Issued |
Array
(
[id] => 14747427
[patent_doc_number] => 20190256887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => Hippo Pathway Bioluminescent Biosensor
[patent_app_type] => utility
[patent_app_number] => 16/177691
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16177691
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/177691 | Hippo pathway bioluminescent biosensor | Oct 31, 2018 | Issued |
Array
(
[id] => 16376619
[patent_doc_number] => 20200325461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => Dnase Variants
[patent_app_type] => utility
[patent_app_number] => 16/757557
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757557 | DNase variants | Oct 25, 2018 | Issued |
Array
(
[id] => 14836231
[patent_doc_number] => 20190276516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => ALPHA1 -ANTITRYPSIN COMPOSITIONS AND METHODS OF TREATING AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/166990
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166990
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166990 | a1-antitrypsin compositions and methods of treating autoimmune diseases | Oct 21, 2018 | Issued |
Array
(
[id] => 16261469
[patent_doc_number] => 10752890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Protease variants and polynucleotides encoding same
[patent_app_type] => utility
[patent_app_number] => 16/163660
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 38577
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16163660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/163660 | Protease variants and polynucleotides encoding same | Oct 17, 2018 | Issued |
Array
(
[id] => 14019327
[patent_doc_number] => 20190071657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Engineered CRISPR-Cas9 Nucleases
[patent_app_type] => utility
[patent_app_number] => 16/155808
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155808
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/155808 | Engineered CRISPR-Cas9 nucleases | Oct 8, 2018 | Issued |
Array
(
[id] => 16893410
[patent_doc_number] => 11034946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Glycosylation independent proteins
[patent_app_type] => utility
[patent_app_number] => 16/153371
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6480
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153371
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/153371 | Glycosylation independent proteins | Oct 4, 2018 | Issued |
Array
(
[id] => 14208833
[patent_doc_number] => 20190116801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => FUSION PROTEINS AND METHODS FOR STIMULATING PLANT GROWTH, PROTECTING PLANTS FROM PATHOGENS, AND IMMOBILIZING BACILLUS SPORES ON PLANT ROOTS
[patent_app_type] => utility
[patent_app_number] => 16/145628
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16145628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/145628 | Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing | Sep 27, 2018 | Issued |
Array
(
[id] => 14778689
[patent_doc_number] => 20190264242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => METHODS FOR INCREASING PRODUCT YIELDS
[patent_app_type] => utility
[patent_app_number] => 16/137264
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16137264
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/137264 | METHODS FOR INCREASING PRODUCT YIELDS | Sep 19, 2018 | Abandoned |
Array
(
[id] => 16191149
[patent_doc_number] => 20200231998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => HETEROLOGOUS PRODUCTION OF 10-METHYLSTEARIC ACID BY CELLS EXPRESSING RECOMBINANT METHYLTRANSFERASE
[patent_app_type] => utility
[patent_app_number] => 16/648117
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648117 | Heterologous production of 10-methylstearic acid by cells expressing recombinant methyltransferase | Sep 19, 2018 | Issued |
Array
(
[id] => 14468481
[patent_doc_number] => 20190185883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => CAS9 PROTEINS INCLUDING LIGAND-DEPENDENT INTEINS
[patent_app_type] => utility
[patent_app_number] => 16/132276
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16132276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/132276 | CAS9 proteins including ligand-dependent inteins | Sep 13, 2018 | Issued |
Array
(
[id] => 14231091
[patent_doc_number] => 20190127718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => SUPPRESSION OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/126706
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16126706
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/126706 | SUPPRESSION OF CANCER | Sep 9, 2018 | Abandoned |
Array
(
[id] => 16671411
[patent_doc_number] => 20210060174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => PROTEIN DELIVERY TO MEMBRANES
[patent_app_type] => utility
[patent_app_number] => 16/644354
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644354
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644354 | Protein delivery to membranes | Sep 6, 2018 | Issued |